Skip to main content
Evidence-based Complementary and Alternative Medicine : eCAM logoLink to Evidence-based Complementary and Alternative Medicine : eCAM
. 2013 Mar 6;2013:140509. doi: 10.1155/2013/140509

Chemistry and Biology of Essential Oils of Genus Boswellia

Hidayat Hussain 1,2,*, Ahmed Al-Harrasi 1, Ahmed Al-Rawahi 1, Javid Hussain 1
PMCID: PMC3606720  PMID: 23533463

Abstract

The properties of Boswellia plants have been exploited for millennia in the traditional medicines of Africa, China, and especially in the Indian Ayurveda. In Western countries, the advent of synthetic drugs has obscured the pharmaceutical use of Boswellia, until it was reported that an ethanolic extract exerts anti-inflammatory and antiarthritic effects. Frankincense was commonly used for medicinal purposes. This paper aims to provide an overview of current knowledge of the volatile constituents of frankincense, with explicit consideration concerning the diverse Boswellia species. Altogether, more than 340 volatiles in Boswellia have been reported in the literature. In particular, a broad diversity has been found in the qualitative and quantitative composition of the volatiles with respect to different varieties of Boswellia. A detailed discussion of the various biological activities of Boswellia frankincense is also presented.

1. Introduction

The genus Boswellia has approximately 20 species occurring in the dry regions spanning from west Africa to Arabia and south to the northeast region of Tanzania. In addition, its species have been found in India and Madagascar. The genus is centered in northeast Africa, where approximately 75% of the species are endemic to the area. Members of this genus are trees or shrubs that are described as having outer barks that peel in parchment flakes, a greenish inner bark, watery aromatic resins, and wood with a milky latex [1].

Frankincense, or olibanum, is the oleogum resin that is harvested from several different trees belonging to the genus Boswellia. The word frankincense is derived from the ancient French name “frankincense,” meaning “pure incense.” Frankincense is also known in Arabic as “luban,” which means “white” or “cream;” in Greek as “libanos;” in Ethiopia as “etan” [28]. Olibanum (frankincense) has been used as incense since ancient times [9, 10]. In recent years, it has been important in the preparation of cosmetics and perfumes. In addition, olibanum has anti-inflammatory, sedative, anti-hyperlipidemic, and antibacterial activities in Unani (Islamic) and Chinese traditional medicines [915].

For at least 5000 years, olibanum has been an important trade material for the civilizations located in North Africa and the Arabian Peninsula. It was a precious commercial material even before Christian times because of the interest in this incense material of the old kings and queens, such as the Queen of Saba in 700 B.C. With the dawn of Christianity, it was mentioned in the Bible as one of the presents in which the three wise men had brought to Jesus on the night he was born [16]. The wide use of this resin in religious ceremonies as incense material is still important in the Roman Catholic, Episcopal, and eastern Orthodox churches. Therefore, both the production and export of olibanum is an economic priority for countries like Somalia, Ethiopia, Oman, South Arabia, and India. Olibanum has been utilized as an important fixative in perfumes, soaps, creams, lotions, and detergents in the leading products of the perfume and cosmetic industry, as it has an oriental note in its scent. The interest of pharmaceutical companies created a third market for olibanum. Since ancient times, it has been used in folk medicine for its antiseptic, antiarthritic, and anti-inflammatory effects. For this reason, olibanum has gained increasing attention from scientists in the last 20 years to better define its medical effects and identify the constituents that are responsible for these effects [16].

2. Volatile Constituents of Boswellia

Investigations of the resin and essences or extracts of Boswellia, with regard to the specific volatile constituents, were reported in a series of studies [1635] (Table 1). The chemical characterization procedures enabled a total of 340 volatiles to be identified. Due to the resin nature of frankincense, it is not surprising that the major part of the constituent volatiles belonged to the terpene and sesquiterpene families or their terpenoid derivatives (Table 1). The common compounds included α- and β-pinene, limonene, myrcene, linalool, and several others. Additionally, a series of purely hydrocarbon-terpene compounds was found. More than 30 compounds from the sesquiterpene and diterpene fractions have been identified, for example, α-cubebene, γ-cadinene, β-bourbonene, and α-phellandrene dimer, which was first reported by Basar [16]. Several oxygenated isoprenoid derivatives have also been identified, such as carbonyl derivatives (e.g., carvone, fenchone) and alcohol-containing terpene and sesquiterpene derivatives (e.g., trans-pinocarveol, cis-verbenol, and cembrenol), as well as ester-containing compounds (e.g., α-terpinyl acetate and bornyl acetate). In addition to these isoprenoid-derived compounds, a series of straight-chain alkyl-esters, such as octyl acetate and alcohols (decanol, hexanol), have been detected. Analyzing B. serrata by hydrodistillation, Singh et al. [22], Verghese et al. [23], and Camarda et al. [24] each found α-thujene to be the dominant substance. However, the specific values were in the range 22.7–61.4%. Although, Basar [16] claimed that myrcene was the prevalent volatile (38%), followed by α-thujene (12%). α-Pinene was found in all samples, with the relative amounts in the range of 3.3–11.2%. In the hydrodistillate of B. carter and B. sacra, the values of the detected substances differed to a major extent. Basar [16] claimed that octyl acetate (39.9%) was the main constituent, followed by 1-octanol (11.9%). Al-Harrasi and Al-saidi [25] found limonene (33.5%) and (E)-β-ocimene (32.2%) to be the predominant compounds, whereas Marongiu et al. [26] claimed that octanol acetate was the main volatile (45.2%), followed by phyllocladene (13.2%) and incensole acetate (13%). Mikhaeil et al. [20] identified duva-3,9,13-trien-1,5a-diol-1-acetate as the main volatile (21.4%), followed by octyl acetate (13.4%). Like Al-Harrasi, Camarda et al. [24] also reported limonene to be the dominant substance, albeit at half the abundance found by Al-Harrasi (18.2%). Furthermore, Camarda identified α-pinene as the second most abundant substance (15.1%). However, this finding is in contrast to other studies, in which the α-pinene contents were reported in the range of 0.7–15.1%. Baser et al. [27], Basar [16], and Camarda et al. [24] all claimed that limonene was the main constituent of B. rivae, with values in the range of 14.8–28.0%. Again, another dominant substance seemed to be α-pinene, with relative values of 5.3–16.7%. In agreement with this, α-pinene, together with α-thujene, was found as the dominant substance in B. neglecta, whereas the most abundant volatile in B. papyrifera was octyl acetate at 63.5% [24] and 56% [36]. Furthermore, Basar [16] found that trans-verbenol was the main volatile (15.5%) in B. pirottae and α-pinene (38%) in B. frereana. Summarizing the data from the analyses of the hydrodistillation extracts, α-pinene, limonene, octyl acetate, a-thujene, and (E)-β-ocimene can be regarded as those compounds that have been most frequently reported to be the dominant volatile constituents of the frankincense distillate. Nevertheless, these results do not allow for chemosensory interpretation of their odor contribution to the characteristic frankincense smell. In accordance with the results of the hydrodistillation, Hamm et al. [18] found α-thujene (with a value of 11.7%) to be the dominant volatile in a B. serrata extract obtained by SPME. In Basar's study [16], thujene was also mentioned, but no quantitative data was provided. For the SPME analyses, Basar reported only qualitative data and no quantitative data. Hamm reported α-pinene, limonene, and β-caryophyllene to be the main constituents in B. carteri and B. sacra. By comparison, the α-phellandrene dimer was the dominant volatile (20.2%) in B. frereana, followed by α-pinene (12.4%). Octyl acetate was found in the greatest abundance (64.6%) in B. papyrifera, followed by octanol (13.9%) [1].

Table 1.

Essential oil of Boswellia spp.

Number Compound
1 5,5-Dimethyl-1-vinylbicyclo-[2.1.1]-hexane
2 Anethol
3 Benzyl tiglate
4 trans-α-Bergamotene
5 Bornyl acetate
6 β-Bourbonene
7 Cadinene
8 γ-Cadinene
9 Camphene
10 Camphor
11 m-Camphorene
12 p-Camphorene
13 Carene-3
14 (E)-β-Caryophyllene
15 Cembrene A
16 Cembrenol
17 1,8 Cineol
18 Citronellol
19 α-Copaene
20 β-Copaene
21 p-Cymene
22 m-Cymene
23 Elemol
24 Elemicine
25 epi-Cubenol
26 Estragol
27 Eudesmol
28 10-epi-γ-Eudesmol
29 Fenchone
30 Geraniol
31 Germacrene D
32 Humulene epoxide
33 Isoincensole
34 Isomenthone
35 Kessane
36 Limonene
37 Linalool
38 Linalyl acetate
39 Menthone
40 Methylchavicol
41 Methylisoeugenol
42 Methyleugenol
43 γ-Muurolene
44 Myrcene
45 Neocembrene A
46 Nerolidol
47 cis-β-ocimene
48 (Z)-Ocimene
49 (E)-β -Ocimene
50 Perillene
51 α-Phellandrene
52 β-Phellandrene
53 α-Pinene
54 β-Pinene
55 trans-Pinocarveol
56 Sabinene
57 cis-Sabinol
58 Terpinin-4-ol
59 Terpinen-4-ol
60 Terpinolene
61 α-Terpineol
62 α-Terpinene
63 α-Terpinene
64 γ-Terpinene
65 Terpinyl acetate
66 Terpinyl isobutyrate
67 Tetrahydrolinalool
68 α-Thujene
69 α-Thujone
70 β-Thujone
71 Tricyclene
72 Undecenol
73 trans-Verbenol
74 β-Ylangene
75 Zingiberene
76 Abieta-8,12-diene
77 α-Amorphene
78 alloaromadendrene
79 Benzyl benzoate
80 Beyerene
81 Bisabolene
82 Isopentyl-2-methylbutanoate
83 cis-Calamenene
84 α-Cadinene
85 τ-Cadinol
86 2-Carene
87 Campholenealdehyde
88 Caryophyllene oxide
89 cis-Carveol
90 (+) trans-Carveol
91 Carvone
92 α-Cedrene
93 Cedrol
94 Cembra-1,3,7,11-tetraene
95 Cembra-3,7,11,15-tetraene
96 Cembrene
97 Cembrene C
98 Citronellyl acetate
99 α-Cubebene
100 β-Cubebene
101 o-Cymene
102 Chrysanthenone
103 1,4-Cyclohexadiene
104 p-Cymen-8-ol
105 Decanol
106 Decyl acetate
107 2,6-Dimethoxytoluene
108 3,5-Dimethoxytoluene
109 Duva-3,9,13-trien-1,5α-diol
110 Duva-4,8,13-trien-1a,3α-diol
111 Duva-3,9,13-trien-1,5α-diol-1-acetate
112 Duva-3,9,13-triene-1α-ol-5,8-oxide-1-acetate
113 β-Elemene
114 Farnesyl acetate
115 Geranyl acetate
116 α-Gurjunene
117 Hedycariol
118 1,3,6-Trimethylencycloheptane
119 1-Hexanol
120 Hexyl acetate
121 Hexyl hexanoate
122 α-Humulene
123 Incensole
124 Incensole acetate
125 Isodurene
126 Isocembrene
127 Isophyllocladene (kaur-15-ene)
128 Kaurene
129 Ledol
130 Maaliane
131 p-Mentha-1,5-dien-8-ol
132 o-Methyl anisole
133 α-Muurolene
134 α-Muurolol
135 Myrtenal
136 Naphthalene
137 Naphthalene 1,2,3,4,4a,7-hexahydro-1,6-dimethyl-4-(1-methylethyl
138 Neryl acetate
139 cis-Nerolidol
140 (S)-trans-Nerolidol
141 (E)-Nerolidol
142 1-Octanol
143 n-Octanol
144 Octanol acetate
145 Octyl acetate
146 Octyl formate
147 allo-Ocimene
148 Phenanthrene-7-ethenyl-9,10,10a-dodeca-hydro-1-1-4a-
7-tetramethyl
149 α-Phellandrene epoxide
150 Phyllocladene
151 α-Pinene-epoxide
152 1-β-Pinene
153 2-β-Pinene
154 Isopinocampheol
155 Piperitone
156 Pyrimidine
157 Sabinyl acetate
158 Sandaracopimara-8(14)-15-diene
159 Sclarene
160 α-Selinene
161 β-Selinene
162 δ-Selinene
163 trans-Terpine
164 4-Terpineol
165 Terpinolene
166 Isoterpinolene
167 2,4(10)-Thujadiene
168 Thujopsene
169 Thunbergol
170 Isomyl-valerate
171 Verticilla-4(20),7,11-triene
172 Verbenone
173 cis-Verbenol
174 Verticiol
175 Viridiflorol
176 Benzene, 1methoxy-2-methyl
177 endo-Borneol
178 γ-Campholene aldehyde
179 α-Campholene aldehyde
180 Cara-2,4-diene
181 Carvacrol
182 Carvotanacetone
183 trans-Dihydrocarvone
184 Cumin alcohol
185 m-Cymene-8-ol
186 p-Cymene-9-ol
187 p-Cymenene
188 Dodecanol
189 Eucalyptol
190 Eucarvone
191 Isopropyl benzaldehyde
192 Isopropyl benzalcohol
193 cis-1,2-Limonene epoxide
194 8,9-Limonene epoxide II
195 8,9-Limonene-epoxide I
196 trans-1,2-Limonene epoxide
197 cis-Linalool oxide
198 trans-Linalool oxide
199 p-Mentha-1,5-diene-7-ol
200 p-Mentha-1,8-diene-4-ol
201 cis-p-Menth-2-en-1-ol
202 cis-p-Mentha-1(7),8-diene-2-ol
203 cis-p-Mentha-2,8-diene-1-ol
204 trans-p-Menth-2-en-1-ol
205 trans-p-Mentha-1(7),8-diene-2-ol
206 trans-p-Mentha-2,8-diene-1-ol
207 2,4(8)-p-Menthadiene
208 p-Mentha-6,8-dien-2-one
209 p-Methylanisole
210 Myrtenol
211 Nerol
212 trans-Ocimene
213 (E)-β-Ocimene epoxide
214 α-Phellandrene-dimer
215 α-Phellandrene-8-ol
216 α-Pinene oxide
217 Pinocamphone
218 Pinocarvone
219 Piperitenone
220 Isopiperitenone
221 trans-Piperitol
222 α-Terpineol
223 Sabina ketone
224 cis-Sabinene hydrate
225 trans-Sabinene hydrate
226 trans-Sabinol
227 2,5-Dimethylstyrene
228 cis-1,2-Epoxy-terpin-4-ol
229 Thuj-3-en-10-al
230 Thujanol
231 Thunbergene
232 Thymol
233 Umbellulone
234 Verticellol
235 5,5-Dimethyl-1-vinylbicyclo-[2.1.1]-hexane
236 p-Anisaldehyde
237 Aromadendrene
238 Benzyl tigilate
239 p-Camphorene
240 Isocaryophyllene
241 Cumaldehyde
242 Cyclosativene
243 γ-Eudesmol
244 Guaioxide
245 5-Guaiene-11-ol
246 Isogermacrene D
247 4-Methylene-1-(1-methylethyl)-bicyclo[3.1.0]hex-2-ene
248 2-Methyl-5-(1-methylethyl)-1,3-cyclohexadiene monoepoxide
249 n-Pentadecan
250 Perilla alcohol
251 Perillol
252 Thujol
253 m-Thymol
254 α-Ylangene
255 γ-Campholene aldehyde
256 n-Decanoic acid
257 β-Eudesmene
258 β-Cyclogeranylacetate
259 n-Hexanoic acid
260 Hexylcaprylate
261 Incensyl acetate
262 Incensole oxide
263 Incensole oxide acetate
264 Lauric acid
265 p-Methylacetophenone
266 p-Methyleugenol
267 β-Myrcene
268 n-Nonanoic acid
269 n-Octanoic acid
270 3,4-Dimethoxystyrene
271 α-Cadinol
272 1,Hydroxy-1,7-dimethyl-4-isopropyl-2,7-cyclodecadiene
273 1,5,5,8-Tetramethyl-12-oxabicyclo-[9.1.0]-dodeca-3,7-diene
274 1-Methyl-4-(1-methylethenyl)-1,2-cyclohexanediol
275 trans-p-Mentha-2,8-dienol
276 1,2,3,4,6,8a-hexahydro-1-isopropyl-4,7-dimethyl-
naphthalene
277 2-Isopropenyl-4a,8-dimethyl-1,2,3,4,4a,5,6,8a-ctahydronaphthalene
278 3,5-Dimethoxytoluene
279 (Z)-α-Hydroxymanool
280 Hydroxy-manool
281 Methyl linoleate
282 1-Acetyl-4-isopropenylcyclopentene
283 2,4-Dimethylacetophenone
284 α-Amyrenone
285 β-Amyrenone
286 10-Hydroxy-4-cadinen-3-one
287 2-Hydroxy-1,4-cineole
288 Cryptone
289 Eucarvone
290 Isopropylidencyclohexane
291 1,2,4-Trihydroxy-p-menthane
292 Δ4-p-Menthen-2-one
293 5-Hydroxy-p-menth-6-en-2-one
294 Myrtenoic acid
295 Nopinone
296 3,6,6,-Trimethyl-norpinan-2-one
297 o-Methylacetophenone
298 Perillaaldehyde
299 Phellandra
300 Pinocamphone/isopinocamphone
301 Thujone
302 24-Noroleana-3,12-diene
303 24-Noroleana-3,9(11),12-triene
304 24-Norursa-3,12-diene
305 24-Norursa-3,9(11),12-triene
306 24-Norursa-3.12-dien-11-one
307 α-Amyrine
308 epi-α-Amyrine
309 β-Amyrine
310 Lupeol
311 Terpinenyl acetate
312 1,5-Isopropyl-2-methylbicyclo[3.1.0]hex-3-en-2-ol
313 α-Campholenal
314 (3E,5E)-2,6-Dimethyl-1,3,5,7-octatetraene
315 (E)-2,3-Epoxycarene
316 3,4-Dimethylstyrene
317 1-(2,4-Dimethylphenyl)ethanol
318 4-Methylbenzoic acid
319 p-Menth-1(7)-en-2-one
320 Caryophyllene
321 Methylcycloundecanecarboxylate
322 Nonanoic acid
323 Hexadecanoic acid
324 1,4-Cineol
325 Sabinene hydrate
326 Methyl-trans-2-cis-4-decadienoate
327 2-Hydroxy-5-methoxy-acetophenone
328 (E)-β-Farnesene
329 2-Dodecenoic acid methyl ester
330 Calacorene
331 n-Dodecanoic acid
332 α-Guaiol
333 Caryophylla-3(15),7(14)-dien-6-ol
334 Cadalene
335 Eudesma-4(15),7-dien-1β-ol
336 n-Heptadecane
337 n-Tetradecanoic acid
338 n-Octadecane
339 Galaxolide
340 Manool

Al-Saidi et al. [34] reported the volatile chemical profile and physicochemical characteristics of four commercial grades of botanically certified oleogum resins of B. sacra, known as Hoojri, Najdi, Shathari, and Shaabi, were studied. The striking feature of Al-Saidi et al. [34] study was the presence of high amounts of α-pinene in all four oils, which can be considered as a chemotaxonomical marker that confirms the botanical and geographical source of the resins. Even though many Boswellia species produce frankincense, the major sources of commercial frankincense are B. serrata (India), B. sacra (Oman), and B. carteri (Somalia). The reports on the oil composition of B. serrata revealed a wide variation of major constituents, but none of the studies reported α-pinene as the most abundant component. Similarly, reports on the oil composition of B. carteri from Somalia also showed variation within the major constituents, suggesting a possible existence of different chemotypes. The Al-Saidi et al. [34] study reveals that the composition pattern of three of the Omani luban oils, that is, the Hoojri, Shathari, and Shaabi oils, was different from the above cited studies in terms of the major constituent α-pinene. The Najdi oil, however, showed some similarity with the Somalian B. carteri sample studied by Abdel Wahab et al. [37], with α-pinene and limonene as the major constituents. The variation observed might be expected, based on several factors such as climatic changes, harvest conditions, and geographical source.

Since the entire history of Boswellia nomenclature is fraught with misidentification, Woolley et al. [35] showed that the history of inaccurate frankincense taxonomy also applies to the widespread error of identifying B. carterii as being synonymous with B. sacra. Woolley et al. [35] studied the essential oil of B. carterii and B. sacra and showed that B. carterii can always be identified by the key markers viridiflorol, cembrenol, dimethyl ethermorcinol, and most importantly incensole. B. sacra was distinguished by higher quantities of α-pinene and delta-3-carene, while B. carterii possessed higher quantities of α-thujene, myrcene, limonene, trans-β-caryophyllene, germacrene D, and incensole. Woolley et al. [35] hypothesize that the differences in enantiomeric pair ratios of monoterpenes in Arabian B. sacra and African B. carterii resins were due to the differences in the abundance of genetically expressed chiral-specific enzymes for monoterpene biosynthesis. The most likely cause of genetic shift and speciation of B. sacra trees in Arabia and B. carterii trees in East Africa was the geological isolation created by the Red Sea Rift Valley that has separated these two tectonic plate land masses. Genetic mapping of these species might provide conclusive data to support Woolley et al. observations. Woolley et al. concluded that B. sacra and B. carterii are different species based on enantiomeric pair ratios and optical rotation.

Although α-pinene was the major compound and found in high concentrations in all grades of Omani frankincense (B. sacra) [34], this compound cannot be considered as a chemotaxonomic marker for B. sacra because of its frequent occurrence in other species of Boswellia (Table 2). Frankincense is a natural oleo-gum resin whose ingredients may depend on many factors, such as location, climate, time of harvest, and other environmental conditions. An indication of this variance could be clearly seen when comparing the different results of the samples of the same species (Table 2). A remarkable diversity of the predominant compounds in similar Boswellia species reported by different authors is clearly seen in Table 2. For example myrcene and α-thujene were individually reported to be major compounds for B. serrata. Mikhaeil et al. [20] reported duva-3,9,13-triene-1a-ol-5,8-oxide-1-acetate to be a major compound in the essential oil of B. carteri whereas Basar [16] found octyl acetate to be a major compound for the same species. Limonene, α-pinene, and octanol were reported individually to be major constituents for B. rivae. The incompatibility between the results mentioned in different literature could still be logical due to the influence of several factors mentioned earlier such as the climate, harvest conditions, and geographical source. However, such contradicting results make it difficult to rely on the chemical profile of the oil as a chemotaxonomic marker to distinguish between the different commercial varieties of frankincense.

Table 2.

Percentages of major compounds in the essential oils of reported Boswellia species.

Boswellia specie Method of obtaining resin Predominant compound(s) Percentage (%) Literature
B. serrata Obatined from Willy Benecke GmbH (Hamburg, Germany) Myrcene 38 [16]
B. serrata NA α-Thujene 22.7–47.4 [22]
B. serrata NA α-Thujene 29.3 [24]
B. serrata NA α-Thujene 61.36 [23]
B. carteri Purchased from the local market of herbs and spices in Egypt Duva-3,9,13-triene-1a-ol-5,8-oxide-1-acetate 21.4 [20]
B. sacra Botanically certified oleogum resin E-β-Ocimene 32.3 [25]
B. carteri/sacra NM Octanol acetate 45.2 [26]
B. carteri Authentic sample from Ethiopia certified for its authenticity from the Agricultural Department of the Ethiopian government Octyl acetate 39.3 [16]
B. rivae NA Limonene 28.0 [24]
B. rivae Authentic sample from Ethiopia α-Pinene 16.7 [16]
B. rivae NA α-Pinene 13.3 [24]
B. rivae NA Octanol 17.8 [24]
B. neglecta NA α-Pinene 16.7 [27]
B. neglecta Authentic sample from Ethiopia α-Pinene 21.3 [16]
B. papyrifera NA Octyl acetate 63.5 [24]
B. papyrifera NA Octyl acetate 56.0 [36]
B. pirottae NA Trans-Verbenol 15.5 [27]
B. pirottae NA Terpinen-4-ol 14.6 [27]
B. frereana Willy Benecke GmbH (Hamburg, Germany) α-Pinene 38.0 [16]

NA: not available.

3. Biological Activities of Essential Oils

3.1. Antioxidant Activity

Awadh Ali et al. [29] evaluated essential oils of Boswellia species for antioxidant activity. The essential oils were able to reduce the stable free radical DPPH with IC50 values of 121.4 μg/mL, 211.2 μg/mL, and 175.2 μg/mL for B. socotrana, B. elongate, and B. ameero, respectively. The positive factor for B. socotrana essential oils was the higher concentration of oxygenated monoterpenes [38, 39], but there are no data on the antioxidant activity of the oxygenated monoterpene (E)-2,3-epoxycarene, which is the main constituent in this oil. Boswellia essential oils showed lower free radical scavenging activity in comparison to other reported essential oils rich in oxygenated monoterpenes, such as Melissa officinalis and M. piperita with IC50 = 7.58 and 2.53 μg/mL, respectively [40, 41].

Recently, Mothana et al. [31] also evaluated the antioxidant activity of essential oils of Boswellia, demonstrating only weak antioxidant abilities in the reduction of DPPH. The three essential oils of B. dioscorides, B. elongate, and B. socotrana exhibited weak radical scavenging effects (22%, 21%, and 28%, resp.) at a concentration of 1 mg/mL. In comparison, ascorbic acid had a 96% antioxidant effect. This observation was certainly associated with the low content of phenolic components, such as thymol and carvacrol, in the three investigated oils [39].

3.2. Acetylcholinesterase Inhibition

Awadh Ali et al. [29] also evaluated the AChE inhibition of essential oils of Boswellia species. At a concentration of 200 μg/mL, essential oils of B. socotrana (59.3% inhibition) exhibited higher AChE inhibition than the essential oils of B. elongata and B. ameero (29.6 and 41.5% inhibition, resp.). The AChE inhibitory activity of B. socotrana oil may be due to the presence of (E)-2,3-epoxycarene and p-menth-1(7)-en-2-one, which belong to a group of monoterpenoid skeletons reported to have AChE inhibitory activity [42, 43]. Pulegone, a monoterpene with a p-menthane skeleton in Mentha spp, showed AChE inhibition with an IC50 of 890 μM [42].

3.3. Antimicrobial Activity

Camarda et al. [24] investigated the antimicrobial efficacy of B. carteri against Escherichia coli, Pseudomonas aeruginosa, and three strains of Staphylococcus aureus. Inhibitory activity was found against all pathogens, with the highest sensitivity noted for P. aeruginosa at concentrations as low as 6.6 μg/mL. Conversely, the essential oil of B. carterii was investigated for inhibitory activity against a Methicillin-resistant Staphylococcus aureus (MRSA) strain using a disc diffusion assay and found to have no inhibitory activity. In addition, Van et al. [32] reported that different fractions of essential oils of B. carteri, B. neglecta, B. sacra, B. thurifera, and B. frereana showed moderate to poor activity against a reference S. aureus strain (ATCC 12600).

Mothana et al. [31] evaluated the antimicrobial activity of B. dioscorides, B. elongate, and B. socotrana oils against two Gram-positive bacteria, two Gram-negative bacteria, and one fungal strain. The results indicated that the oils had varying degrees of growth inhibition against the bacterial strains. However, no activity was registered against the fungus Candida albicans. The Gram-positive strains showed more susceptibility to the tested essential oils than the Gram-negative ones. The essential oil of B. socotrana demonstrated the strongest activity with the lowest MIC values (1.87 mg/mL) obtained against Staphylococcus aureus and Bacillus subtilis.

Another study by Camarda et al. [24] demonstrated that the essential oils of four Boswellia species exhibited significant antifungal activity against both Candida albicans and Candida tropicalis. Camarda et al. [24] and Shao et al. [43] reported that limonene present in the essential oils was the component responsible for the antifungal activity. Hence, the absence of limonene in the essential oils explored by Mothana et al. [31] explained the lack of antifungal activity.

The MIC values of the tested essential oils were relatively lower than those of the positive controls (3.5–7.0 lg/mL). However, as crude oils, the overall antimicrobial activity screening results were still indicative of the potential of these herbal drugs to be effective treatments for bacterial infections. Moreover, oxygenated monoterpenes, such as camphor, borneol, linalool, and α-terpineol, were reported to be responsible for the antimicrobial activity of several essential oils [44, 45]. Consequently, the high antibacterial efficacy of B. socotrana could be attributed to the high percentage of oxygenated monoterpenes, such as camphor, α-fenchol, terpinen-4-ol, and borneol. Moreover, the predominance of 2-hydroxy-5-methoxy-acetophenone (16.3%) could have contributed to the strong activity [31].

Furthermore, B. rivae resin essential oil was tested for its antifungal activity against Candida albicans ATCC 10231. In previous reports, B. rivae essential oils showed the lowest MIC value of 2.6 μg/mL (0.3% v/v) against the same strain of C. albicans [24] among the oils tested. As hyphal formation is a morphogenetic process that contributes to the virulence of C. albicans [46], Schillaci et al. [47] opted to test the oil anti-germ tube formation activity. In this case, B. rivae oil demonstrated a particularly good activity as an inhibitor of germ tube formation with an IC50 value of 0.12 μg/mL (0.014% v/v). Thus, such low IC50 values for B. rivae were a good indication that this oil also had demonstrable antibiofilm activity. In fact, the authors observed the prevention of adhesion and biofilm formation at a sub-MIC concentration of 0.88 μg/mL (0.1% v/v). Moreover, the oil was significantly active at a concentration of 44.1 μg/mL (5% v/v) against a preformed 24 h old C. albicans biofilm [47]. The chief chemical component of B. rivae oleogum resin oil was limonene (28%), a monoterpene hydrocarbon with demonstrated antifungal activity [48]. However, it is difficult to attribute the anti-biofilm activity to one single component, and further studies are needed to understand the role of the components of such oil in the biological activity.

Al-Saidi et al. [34] reported antibacterial activity of oleo-gum resins of B. sacra, known as Hoojri, Najdi, Shathari, and Shaabi against. All the four oils were effective against both Gram-positive and Gram-negative bacteria. The clinical isolates of Bacillus subtilis, Micrococcus luteus, Staphylococcus aureus, Klebsiella pneumoniae, and Enterobacter aerogenes were sensitive to all the oils, while those of Pseudomonas aeruginosa, Escherichia coli, and Proteus vulgaris were resistant to the Shathari, Najdi, and Hoojri oils, respectively. The resistance of some of the Gram-negative bacteria to some of the oils could be due to the more hydrophilic outer membrane containing lipopolysaccharide. Small hydrophilic molecules are able to pass the outer membrane through porin channels, while the outer membrane acts as a penetration barrier for macromolecules and hydrophobic compounds. But the outer membrane is not completely impermeable to hydrophobic molecules; some of them can slowly pass through the porins. Hence, passing through the outer membrane contributes to the bactericidal activity of a compound. This could be the possible explanation for the sensitivity of some Gram-negative bacteria to the different luban oils [34].

Recently Abdoul-latif et al. [49] reported the antibacterial activity of essential oils of B. sacra and B. papyrifera. The best zone of inhibition of essential oil of B. sacra for bacteria was obtained for Enterococcus faecalis (37 mm), Shigella dysenteria (37 mm), Salmonella enterica (35 mm), Bacillus cereus (34 mm), and Listeria innocua (34 mm). Similarly best zone of inhibition of essential oil of B. papyrifera for bacteria was obtained for Salmonella enterica (40 mm), Bacillus cereus (39 mm), Enterococcus faecalis (39 mm), Shigella dysenteria (31 mm), and Staphylococcus camorum (30 mm). Interestingly essential oils of B. sacra and B. papyrifera present an antimicrobial activity stronger than the tetracycline.

3.4. Anticancer Activity

Frankincense oil-induced cell viability was investigated for essential oils of B. carterii in human bladder cancer J82 cells and immortalized normal bladder urothelial UROtsa cells [50]. The results showed that within a range of concentrations, frankincense oil suppressed cell viability in bladder transitional carcinoma J82 cells but not UROtsa cells. Comprehensive gene expression analysis confirmed that frankincense oil activated genes that were responsible for cell cycle arrest, cell growth suppression, and apoptosis in J82 cells. However, frankincense oil-induced cell death in J82 cells did not result in DNA fragmentation, a hallmark of apoptosis. Therefore, frankincense oil appeared to distinguish cancerous from normal bladder cells and suppress cancer cell viability. Microarray and bioinformatics analysis proposed multiple pathways that could be activated by frankincense oil to induce bladder cancer cell death [50].

Recently, Suhail et al. [51] showed that B. sacra essential oil suppressed important malignant features of tumor cells, such as invasion and multicellular tumor spheroid growth. Tumor cell plasticity enables highly malignant tumor cells to express endothelial cell-specific markers and form vessel-like network structures on basement membranes. The in vitro Matrigel-based tumor invasion model has been shown to correlate with in vivo metastatic potential [52]. This in vitro model has been used to study mechanisms of cancer aggressive behavior, metastasis, and poor prognosis [53], and it has been used as a tool to screen therapeutic agents for antimetastatic activity [54, 55]. MDA-MB-231 cells grown on Matrigel are more resistant to essential oil-suppressed cell viability than cells grown on tissue culture plates. This difference may result from the protective effects of the Matrigel basement membrane matrix enriched with various growth factors. In addition, cancer cells can form multicellular spheroid aggregates, which afford protection for cancer cells against some chemotherapeutic agents [56].

Multicellular tumor spheroids in culture have been used as an in vitro model for screening and testing anticancer drugs [57]. Similar to results from cytotoxicity and apoptosis, B. sacra essential oil obtained at 100°C in hydrodistillation is more potent than essential oil obtained at 78°C in disruption of cellular networks on Matrigel and spheroids. More importantly, observations obtained in the above-described experimental models were consistent with clinical responses in human cancer cases. These results suggested that B. sacra essential oil might represent an effective therapeutic agent for treating invasive breast cancer.

Aberrant activations of Akt and ERK1/2 MAPK signaling molecules have been identified in various cancers including breast cancer, and activations of Akt and ERK1/2 have been suggested as independent cancer prognostic markers. The Akt pathway has been found to be activated in early stages of breast cancer development [58], and activation of Akt signaling protects breast cancer cells from tamoxifen-induced apoptosis in vitro and confers poor prognosis in cancer patients [59, 60]. Activation of ERK1/2 has also been shown to be associated with the development of tamoxifen resistance and patient survival [61, 62]. Both Akt and ERK1/2 have been proposed as molecular targets for treating breast cancer, particularly in antiestrogen-resistant states [63, 64]. Targeting Akt signaling by inhibiting mTRO signaling has been shown to restore cancer responses to chemotherapy drugs [65, 66], and inhibition of both epidermal growth factor receptor (EGFR)/HER2 and MAPK signaling has been shown to result in growth inhibition and apoptosis of EGFR-expressing breast cancer cells [67]. Studies have shown that boswellic acids and AKBA activate the PI3 K/Akt pathway in human colon cancer HT29 cells [68]. Suhail et al. [51] demonstrated that B. sacra essential oil suppressed Akt and ERK1/2 activation in human breast cancer cell lines, except MDA-MB-231. The differences observed between boswellic acids and B. sacra essential oil may result from different tested tumor cell types or components other than boswellic acids present in the essential oil [51].

3.5. Antibiofilm Activity

Schillaci et al. [47] evaluated anti-biofilm activity of the commercially available essential oils from B. papyrifera against the preformed 24 h old biofilms of two bacterial strains: Staphylococcus epidermidis DSM 3269 and Staphylococcus aureus ATCC 29213. Interestingly, the anti-biofilm activity exhibited at the lowest concentrations of 13.6 μg/mL (1.5% v/v) and 6.8 μg/mL (0.75% v/v) was below that of the MIC concentration of 22.6 μg/mL (2.6% v/v), as determined against planktonic forms of both bacterial strains. These data were curious, considering that staphylococcal biofilms are usually resistant to conventional antibiotics at concentrations up to 1000 times the MIC.

4. Conclusion

None of the volatiles identified in the different studies have, according to our knowledge, ever been attributed to the specific smell of frankincense. It is interesting to note, however, that an olibanum-like odour has been reported elsewhere for a substance found in orange oil residue [21] which was identified as cis-iso-cascarilla acid. Nevertheless, this compound has not been reported as a constituent of frankincense in the literature discussed in this paper.

Furthermore, it remains unanswered whether there are substances with frankincense-specific odour qualities, or whether the characteristic smell of frankincense is due to a specific blend of dorants, as often observed in other food or plant aromas. Further research is therefore necessary to elucidate the specific contributors to the aroma profile of frankincense and frankincense pyrolysate. The essential oils of Boswellia plants showed different activities which is summarized in Table 3.

Table 3.

Biological activities of essential oils of Boswellia genus.

Plants Biological activities of essential oils of Boswellia planta
Antioxidant AchEI inhibition Antimycrobial Anticancer Antibiofilm
B. socotrana IC50 121.4 μg/mL, 59.3% Moderate activity NK NK
B. elongata IC50 211.2 μg/mL 29.6 Moderate activity NK NK
B. ameero IC50 175.2 μg/mL 41.5 NK Good activity NK
B. carteri NKa NK Moderate activity NK
B. neglecta NK NK Moderate activity NK
B. sacra NK NK Good activity Good activity NK
B. thurifera NK NK Moderate activity NK
B. frereana NK NK Moderate activity NK
B. dioscorides NK NK Moderate activity NK
B. rivae NK NK Good activity NK
B. papyrifera NK NK Good activity Good activity

aNK: not known.

References

  • 1.Vollesen K. Burseraceae. In: Hedberg I, Edwards S, editors. Flora of Ethiopia. Vol. 3. Addis Ababa, Ethiopia: National Herbarium, Addis Ababa University; 1989. pp. 442–447. [Google Scholar]
  • 2.Dekebo A. Phytochemical studies on the resin of some Commiphora and Boswellia spp. [Ph.D. thesis] Addis Ababa, Ethiopia: Addis Ababa University; 2001. [Google Scholar]
  • 3.Kindeya GH. Ecology and management of Boswellia papyrifera (Del.) Hochst. Dry forest in Tigray, Northern Ethiopia [Ph.D. thesis] Gottingen, Germany: Culvillier; 2003. [Google Scholar]
  • 4.Tucker AO. Frankincense and myrrh. Economic Botany. 1986;40(4):425–433. [Google Scholar]
  • 5.Moussaieff A, Mechoulam R. Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials. Journal of Pharmacy and Pharmacology. 2009;61(10):1281–1293. doi: 10.1211/jpp/61.10.0003. [DOI] [PubMed] [Google Scholar]
  • 6.Ammon HP. Boswellic acids in chronic inflamatory diseases. Planta Medica. 2006;72(12):1100–1116. doi: 10.1055/s-2006-947227. [DOI] [PubMed] [Google Scholar]
  • 7.Poeckel D, Werz O. Boswellic acids: biological actions and molecular targets. Current Medicinal Chemistry. 2006;13(28):3359–3369. doi: 10.2174/092986706779010333. [DOI] [PubMed] [Google Scholar]
  • 8.Shah BA, Qazi GN, Taneja SC. Boswellic acids: a group of medicinally important compounds. Natural Product Reports. 2009;26(1):72–89. doi: 10.1039/b809437n. [DOI] [PubMed] [Google Scholar]
  • 9.Shanghai Scientific and Technologic Press. Dictionary of Chinese Traditional Medicines. Tokyo, Japan: Shogakkan; 1985. [Google Scholar]
  • 10.Safayhi H, Ammon HPT. Pharmakologische Aspecte von Weihrauch und Boswelliasauren. Pharmazeutisch Zeitung. 1997;142:3277–3280. [Google Scholar]
  • 11.Safayhi H, Boden SE, Schweizer S, Ammon HPT. Concentration-dependent potentiating and inhibitory effects of Boswellia extracts on 5-lipoxygenase product formation in stimulated PMNL. Planta Medica. 2000;66(2):110–113. doi: 10.1055/s-2000-11136. [DOI] [PubMed] [Google Scholar]
  • 12.Fan AY, Lao L, Zhang RX, et al. Effects of an acetone extract of Boswellia carterii Birdw. (Burseraceae) gum resin on adjuvant-induced arthritis in lewis rats. Journal of Ethnopharmacology. 2005;101(1–3):104–109. doi: 10.1016/j.jep.2005.03.033. [DOI] [PubMed] [Google Scholar]
  • 13.Büchele B, Zugmaier W, Estrada A, et al. Characterization of 3α-Acetyl-11-keto-α-boswellic acid, a pentacyclic triterpenoid inducing apoptosis in vitro and in vivo. Planta Medica. 2006;72(14):1285–1289. doi: 10.1055/s-2006-951680. [DOI] [PubMed] [Google Scholar]
  • 14.Banno N, Akihisa T, Yasukawa K, et al. Anti-inflammatory activities of the triterpene acids from the resin of Boswellia carteri . Journal of Ethnopharmacology. 2006;107(2):249–253. doi: 10.1016/j.jep.2006.03.006. [DOI] [PubMed] [Google Scholar]
  • 15.Akihisa T, Tabata K, Banno N, et al. Cancer chemopreventive effects and cytotoxic activities of the triterpene acids from the resin of Boswellia carteri . Biological and Pharmaceutical Bulletin. 2006;29(9):1976–1979. doi: 10.1248/bpb.29.1976. [DOI] [PubMed] [Google Scholar]
  • 16.Basar S. Phytochemical investigations on Boswelia species [Ph.D. thesis] Hamburg, Germany: University of Hamburg; 2005. [Google Scholar]
  • 17.Obermann H. Die chemischen und geruchlichen Unterschiede von Weihrauchharzen. Dragoco Report. 1977;24:260–265. [Google Scholar]
  • 18.Hamm S, Bleton J, Connan J, Tchapla A. A chemical investigation by headspace SPME and GC-MS of volatile and semi-volatile terpenes in various olibanum samples. Phytochemistry. 2005;66(12):1499–1514. doi: 10.1016/j.phytochem.2005.04.025. [DOI] [PubMed] [Google Scholar]
  • 19.Basar S, Koch A, König WA. A verticillane-type diterpene from Boswellia carterii essential oil. Flavour and Fragrance Journal. 2001;16(5):315–318. [Google Scholar]
  • 20.Mikhaeil BR, Maatooq GT, Badria FA, Amer MMA. Chemistry and immunomodulatory activity of frankincense oil. Zeitschrift fur Naturforschung C. 2003;58(3-4):230–238. doi: 10.1515/znc-2003-3-416. [DOI] [PubMed] [Google Scholar]
  • 21.Mertens M, Buettner A, Kirchhoff E. The volatile constituents of frankincense—a review. Flavour and Fragrance Journal. 2009;24(6):279–300. [Google Scholar]
  • 22.Singh B, Kumar R, Bhandari S, Pathania S, Lai B. Volatile constituents of natural Boswellia serrata oleo-gum-resin and commercial samples. Flavour and Fragrance Journal. 2007;22(2):145–147. [Google Scholar]
  • 23.Verghese J, Joy MT, Retamar JA, Malinskas GG, Catalan CAN, Gros EG. A fresh look at the constituents of Indian Olibanum oil. Flavour Fragrance Journal. 1987;2(3):99–102. [Google Scholar]
  • 24.Camarda L, Dayton T, Di Stefano V, Pitonzo R, Schillaci D. Chemical composition and antimicrobial activity of some oleogum resin essential oils from Boswellia spp. (Burseraceae) Annali di Chimica. 2007;97(9):837–844. doi: 10.1002/adic.200790068. [DOI] [PubMed] [Google Scholar]
  • 25.Al-Harrasi A, Al-Saidi S. Phytochemical analysis of the essential oil from botanically certified oleogum resin of Boswellia sacra (Omani luban) Molecules. 2008;13(9):2181–2189. doi: 10.3390/molecules13092181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Marongiu B, Piras A, Porcedda S, Tuveri E. Extraction of Santalum album and Boswellia carterii Birdw. volatile oil by supercritical carbon dioxide: influence of some process parameters. Flavour and Fragrance Journal. 2006;21(4):718–724. [Google Scholar]
  • 27.Başer KHC, Demirci B, Dekebo A, Dagne E. Essential oils of some Boswellia spp., myrrh and opopanax. Flavour and Fragrance Journal. 2003;18(2):153–156. [Google Scholar]
  • 28.Pailer M, Scheidl O, Gutwillinger H, Klein E, Obermann H. Über die Zusammensetzung des Pyrolysates von Weihrauch “Aden”, dem Gummiharz von Boswellia carteri Birdw., 1. Mitt. Monatshefte für Chemie. 1981;112(3):341–358. [Google Scholar]
  • 29.Awadh Ali NA, Wurster M, Arnold N, Lindequist U, Wessjohann L. Chemical composition and biological activities of essential oils from the Oleogum resins of three endemic Soqotraen Boswellia species. Records of Natural Products. 2009;2(1):6–12. [Google Scholar]
  • 30.Strappaghetti G, Corsano S, Craveiro A, Proietti G. Constituents of essential oil of Boswellia frereana . Phytochemistry. 1982;21(8):2114–2115. [Google Scholar]
  • 31.Mothana RAA, Hasson SS, Schultze W, Mowitz A, Lindequist U. Phytochemical composition and in vitro antimicrobial and antioxidant activities of essential oils of three endemic Soqotraen Boswellia species. Food Chemistry. 2011;126(3):1149–1154. [Google Scholar]
  • 32.van Vuuren SF, Kamatou GPP, Viljoen AM. Volatile composition and antimicrobial activity of twenty commercial frankincense essential oil samples. South African Journal of Botany. 2010;76(4):686–691. [Google Scholar]
  • 33.Dekebo A, Zewdu M, Dagne E. Volatile oils of frankincense from Boswellia papyrifera . Bulletin of the Chemical Society of Ethiopia. 1999;13(1):93–96. [Google Scholar]
  • 34.Al-Saidi S, Rameshkumar KB, Hisham A, Sivakumar N, Al-Kindy S. Composition and antibacterial activity of the essential oils of four commercial grades of Omani Luban, the oleo-gum resin of Boswellia sacra . Chemistry and Biodiversity. 2012;9(3):615–624. doi: 10.1002/cbdv.201100189. [DOI] [PubMed] [Google Scholar]
  • 35.Woolley CL, Suhail MM, Smith BL, et al. Chemical differentiation of Boswellia sacra and Boswellia carterii essential oils by gas chromatography and chiral gas chromatography-mass spectrometry. Journal Chromatography A. 2012;1261:158–163. doi: 10.1016/j.chroma.2012.06.073. [DOI] [PubMed] [Google Scholar]
  • 36.Dekebo A, Dagne E, Gautun OR, Aasen AJ. Triterpenes from the resin of Boswellia neglecta . Bulletin of the Chemical Society of Ethiopia. 2002;16(1):87–90. [Google Scholar]
  • 37.Abdel Wahab SM, Aboutabl EA, El-Zalabani SM, Fouad HA, de Pooter HL, El-Fallaha B. The essential oil of olibanum. Planta Medica. 1987;53(4):382–384. doi: 10.1055/s-2006-962745. [DOI] [PubMed] [Google Scholar]
  • 38.Baratta MT, Dorman HJD, Deans SG, Biondi DM, Ruberto G. Chemical composition, antimicrobial and antioxidative activity of laurel, sage, rosemary, oregano and coriander essential oils. Journal of Essential Oil Research. 1998;10(6):618–627. [Google Scholar]
  • 39.Ruberto G, Baratta MT. Antioxidant activity of selected essential oil components in two lipid model systems. Food Chemistry. 2000;69(2):167–174. [Google Scholar]
  • 40.Mimica-Dukic N, Bozin B, Sokovic M, Simin N. Antimicrobial and antioxidant activities of Melissa officinalis L. (Lamiaceae) essential oil. Journal of Agricultural and Food Chemistry. 2004;52(9):2485–2489. doi: 10.1021/jf030698a. [DOI] [PubMed] [Google Scholar]
  • 41.Mimica-Dukić N, Božin B, Soković M, Mihajlović B, Matavulj M. Antimicrobial and antioxidant activities of three Mentha species essential oils. Planta Medica. 2003;69(5):413–419. doi: 10.1055/s-2003-39704. [DOI] [PubMed] [Google Scholar]
  • 42.Miyazawa M, Yamafuji C. Inhibition of acetylcholinesterase activity by bicyclic monoterpenoids. Journal of Agricultural and Food Chemistry. 2005;53(5):1765–1768. doi: 10.1021/jf040019b. [DOI] [PubMed] [Google Scholar]
  • 43.Shao Y, Ho CT, Chin CK, Badmaev V, Ma W, Huang MT. Inhibitory activity of boswellic acids from Boswellia serrata against human leukemia HL-60 cells in culture. Planta Medica. 1998;64(4):328–331. doi: 10.1055/s-2006-957444. [DOI] [PubMed] [Google Scholar]
  • 44.Carson CF, Riley TV. Antimicrobial activity of the major components of the essential oil of Melaleuca alternifolia . Journal of Applied Bacteriology. 1995;78(3):264–269. doi: 10.1111/j.1365-2672.1995.tb05025.x. [DOI] [PubMed] [Google Scholar]
  • 45.Pattnaik S, Subramanyam VR, Bapaji M, Kole CR. Antibacterial and antifungal activity of aromatic constituents of essential oils. Microbios. 1997;89(358):39–46. [PubMed] [Google Scholar]
  • 46.Wesenberg-Ward KE, Tyler BJ, Sears JT. Adhesion and biofilm formation of Candida albicans on native and pluronic-treated polystyrene. Biofilms. 2005;2(1):63–71. [Google Scholar]
  • 47.Schillaci D, Arizza V, Dayton T, Camarda L, Di Stefano V. In vitro anti-biofilm activity of Boswellia spp. oleogum resin essential oils. Letters in Applied Microbiology. 2008;47(5):433–438. doi: 10.1111/j.1472-765X.2008.02469.x. [DOI] [PubMed] [Google Scholar]
  • 48.Aggarwal KK, Khanujia SPS, Ahmed A, Kumar TRS, Gupta V, Kumar S. Antimicrobial activity profiles of the two enantiomers of limonene and carvone isolated from the oils of Mentha spicata and Anethum sowa . Flavour and Fragrance Journal. 2002;17(1):59–63. [Google Scholar]
  • 49.Abdoul-latif FM, Obame LC, Bassolé IHN, Dicko MH. Antimicrobial activities of essential oil and methanol extract of Boswellia sacra Flueck. and Boswellia papyrifera (Del.) Hochst from Djibouti. International Journal of Management, Modern Sciences and Technologies. 2012;1:1–10. [Google Scholar]
  • 50.Frank MB, Yang Q, Osban J, et al. Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity. BMC Complementary and Alternative Medicine. 2009;9(article 6) doi: 10.1186/1472-6882-9-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Suhail MM, Wu W, Cao A, et al. Boswellia sacra essential oil induces tumor cellspecific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells. Complementary and Alternative Medicine. 2011;11:129–142. doi: 10.1186/1472-6882-11-129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Feng X, Wu Z, Wu Y, et al. Cdc25A regulates matrix metalloprotease 1 through Foxo1 and mediates metastasis of breast cancer cells. Molecular and Cellular Biology. 2011;31(16):3457–3471. doi: 10.1128/MCB.05523-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Gozgit JM, Pentecost BT, Marconi SA, Otis CN, Wu C, Arcaro KF. Use of an aggressive MCF-7 cell line variant, TMX2-28, to study cell invasion in breast cancer. Molecular Cancer Research. 2006;4(12):905–913. doi: 10.1158/1541-7786.MCR-06-0147. [DOI] [PubMed] [Google Scholar]
  • 54.Sasaki CY, Passaniti A. Identification of anti-invasive but noncytotoxic chemotherapeutic agents using the tetrazolium dye MTT to quantitate viable cells in matrigel. BioTechniques. 1998;24(6):1038–1043. doi: 10.2144/98246cr04. [DOI] [PubMed] [Google Scholar]
  • 55.Liang Z, Wu T, Lou H, et al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Research. 2004;64(12):4302–4308. doi: 10.1158/0008-5472.CAN-03-3958. [DOI] [PubMed] [Google Scholar]
  • 56.Sutherland RM, Eddy HA, Bareham B, Reich K, Vanantwerp D. Resistance to adriamycin in multicellulr spheroids. International Journal of Radiation Oncolology Biolohy Physics. 1979;5(8):1225–1230. doi: 10.1016/0360-3016(79)90643-6. [DOI] [PubMed] [Google Scholar]
  • 57.West GW, Weichselbaum R, Little JB. Limited penetration of methotrexate into human osteosarcoma spheroids as a proposed model for solid tumor resistance to adjurant chemotherapy. Cancer Research. 1980;40(10):3665–3668. [PubMed] [Google Scholar]
  • 58.Lin HJ, Hsieh FC, Song H, Lin J. Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer. British Journal of Cancer. 2005;93(12):1372–1381. doi: 10.1038/sj.bjc.6602862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Cicenas J, Urban P, Vuaroqueaux V, et al. Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2. Breast Cancer Research. 2005;7(4):R394–R401. doi: 10.1186/bcr1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Pérez-Tenorio G, Stål O, Arnesson LG, et al. Activation of Akt/PKB in breast cancer predicts a worse outcome among endocrine treated patients. British Journal of Cancer. 2002;86(4):540–545. doi: 10.1038/sj.bjc.6600126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Svensson S, Jirström K, Rydén L, et al. ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis. Oncogene. 2005;24(27):4370–4379. doi: 10.1038/sj.onc.1208626. [DOI] [PubMed] [Google Scholar]
  • 62.Gee JM, Robertson JF, Ellis IO, Nicholson RI. Phosphrylation of ERk1/2 mitogen-activated protein kinase is associated poor response to anti-hormonal therapy and decreased patient survival in colinical breast cancer. International Journal Cancer. 2001;95(4):247–254. doi: 10.1002/1097-0215(20010720)95:4<247::aid-ijc1042>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  • 63.Frogne T, Jepsen JS, Larsen SS, Fog CK, Brockdorff BL, Lykkesfeldt AE. Antiestrogen-resistant human breast cancer cells require activated Protein Kinase B/Akt for growth. Endocrine-Related Cancer. 2005;12(3):599–614. doi: 10.1677/erc.1.00946. [DOI] [PubMed] [Google Scholar]
  • 64.Cui Y, Parra I, Zhang M, et al. Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance. Cancer Research. 2006;66(11):5950–5959. doi: 10.1158/0008-5472.CAN-05-3243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Beeram M, Tan QTN, Tekmal RR, Russell D, Middleton A, deGraffenried LA. Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling. Annals of Oncology. 2007;18(8):1323–1328. doi: 10.1093/annonc/mdm170. [DOI] [PubMed] [Google Scholar]
  • 66.deGraffenried LA, Friedrichs WE, Russell DH, et al. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt activity. Clinical Cancer Research. 2004;10(23):8059–8067. doi: 10.1158/1078-0432.CCR-04-0035. [DOI] [PubMed] [Google Scholar]
  • 67.Lev DC, Kim LS, Melnikova V, Ruiz M, Ananthaswamy HN, Price JE. Dual blockade of EGFR and ERK1/2 phosphorylation potentiates growth inhibition of breast cancer cells. British Journal of Cancer. 2004;91(4):795–802. doi: 10.1038/sj.bjc.6602051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Liu JJ, Duan RD. LY294002 enhances boswellic acid-induced apoptosis in colon cancer cells. Anticancer Research. 2009;29(8):2987–2991. [PubMed] [Google Scholar]

Articles from Evidence-based Complementary and Alternative Medicine : eCAM are provided here courtesy of Wiley

RESOURCES